● Recruiting

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

Condition: Obstructive Sleep Apnea · Sponsor: Amgen

PhasePhase 3

Planned participants250

Who can joinAll sexes, 18 Years to 99 Years

Healthy volunteersNo

About this study

This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in adults with obstructive sleep apnea (OSA) who are not on PAP therapy and are living with overweight or obesity.

This description comes directly from the study's public registry record.

Talk to the study team

Amgen Call Center · 866-572-6436 · medinfo@amgen.com

Always discuss trial participation with your own doctor first.

Locations (54)

Valley Clinical Trials	Northridge, California, United States	Recruiting
Peninsula Research Associates	Rolling Hills Estates, California, United States	Recruiting
Teradan Clinical Trials	Brandon, Florida, United States	Recruiting
Destiny Research Center	Palmetto Bay, Florida, United States	Recruiting
Clinical Research Center Of Florida	Pompano Beach, Florida, United States	Recruiting
NeuroTrials Research	Atlanta, Georgia, United States	Recruiting
Basil Clinical	Laurelton, New York, United States	Recruiting
Monroe Biomedical Research	Monroe, North Carolina, United States	Recruiting
CTI Clinical Research Center	Cincinnati, Ohio, United States	Recruiting
FutureSearch Trials of Neurology	Austin, Texas, United States	Recruiting
Epic Medical Research - DeSoto	DeSoto, Texas, United States	Recruiting
Sleep Therapy & Research Center	San Antonio, Texas, United States	Recruiting

+ 42 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07226765